PSY124 - Market Access of Nintedanib for Idiopathic Pulmonary Fibrosis: A Cross-Country Review of Access Conditions

Autor: Picavet, E, Soulard, S, Druez, C, Munack, U
Zdroj: In Value in Health October-November 2017 20(9):A566-A566
Databáze: ScienceDirect